Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CDMOs
CDMOs
CDMO Fujifilm Diosynth's restructuring plan may leave up to 240 staffers out of work
Fierce Pharma
Wed, 04/17/24 - 10:04 pm
CDMOs
layoffs
Fujifilm Diosynth Biotechnologies
Lonza adds biologics capacity with $1.2bn Roche deal
Pharmaphorum
Wed, 03/20/24 - 11:17 am
Roche
Lonza
drug manufacturing
Switzerland
CDMOs
Despite pharma growth, Merck KGaA's CDMO slowdown plays into company's overall sales decline
Fierce Pharma
Sun, 03/10/24 - 08:40 pm
Merck KGaA
earnings
CDMOs
Evotec Biologics expands partnership with ABL to develop antibodies against HIV
Biopharma Reporter
Mon, 02/12/24 - 11:10 pm
Evotec Biologics
ABL
CDMOs
HIV
antibodies
As Catalent prepares to join Novo family, CDMO's sales continue to slide
Fierce Pharma
Fri, 02/9/24 - 11:21 am
Catalent
CDMOs
earnings
Novo Nordisk
With record year, Samsung Biologics bucks CDMO industry's troublesome 2023
Fierce Pharma
Thu, 01/25/24 - 11:24 am
Samsung BioLogics
drug manufacturing
CDMOs
Naobios receives $1.87 million to fund human viral challenge agent
Biopharma Reporter
Mon, 12/11/23 - 10:14 am
Naobios
funding
vaccines
CDMOs
Gates Foundation
High-flying Fujifilm splashes $200M to beef up cell therapy capacity
Fierce Pharma
Mon, 12/4/23 - 06:08 pm
Fujifilm
CDMOs
cell therapy
J&J books manufacturing space at Fujifilm Diosynth's upcoming mega-plant in North Carolina
Fierce Pharma
Wed, 11/8/23 - 09:57 pm
JNJ
Janssen
Fujifilm Diosynth Biotechnologies
CDMOs
North Carolina
Lonza expands antibody-drug conjugate production pact, plots 180 new hires
Fierce Pharma
Thu, 10/5/23 - 10:09 am
Lonza
CDMOs
hirings
bioconjugation
Bluebird taps Lonza to boost manufacturing capacity for its gene therapies Zynteglo, Skysona
Fierce Pharma
Thu, 09/28/23 - 10:27 am
Bluebird Bio
gene therapy
Lonza
drug manufacturing
CDMOs
Advent International and Warburg Pincus Name Franco Negron CEO of BioPharma Solutions Following its Proposed Divestiture from Baxter
Yahoo/PR Newswire
Sun, 08/27/23 - 04:32 pm
BioPharma Solutions
Baxter International
CDMOs
Franco Negron
Emergent to lay off 400 staffers, eliminate executive position in pivot away from contract manufacturing
Fierce Pharma
Tue, 08/8/23 - 10:50 pm
Emergent BioSolutions
CDMOs
Narcan
layoffs
Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance
BioSpace
Tue, 05/9/23 - 10:37 am
Catalent
earnings
CDMOs
Danaher backs away from Catalent as CDMO struggles with productivity problems: report
Fierce Pharma
Tue, 04/18/23 - 10:15 am
Catalent
Danaher
M&A
CDMOs
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
CP Wire
Tue, 03/28/23 - 01:48 pm
PharmaBlock
CDMOs
sustainability
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
Tue, 03/28/23 - 12:37 pm
PharmaBlock
CDMOs
sustainability
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
CP Wire
Mon, 03/27/23 - 02:29 pm
PharmaBlock
R&D
Pennsylvania
CDMOs
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Mon, 03/27/23 - 02:15 pm
PharmaBlock
R&D
Pennsylvania
CDMOs
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Medtech Dive
Thu, 02/9/23 - 10:43 am
Medtech
M&A
CDMOs
Pages
1
2
3
4
5
next ›
last »